Clinical Trials Directory

Trials / Unknown

UnknownNCT05443672

Multi-center Study of Deep Learning AI in Breast Mass

A Multi-center Study of Breast Mass Screening and Diagnosis Using Deep Learning AI-based on Real-time Ultrasound Examination

Status
Unknown
Phase
Study type
Observational
Enrollment
1,122 (estimated)
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This multi-center study intends to evaluate the value of the detection and differential diagnosis of breast mass using deep learning AI-based real-time ultrasound examination.

Detailed description

As the most common cancer expected to occur all over the world, extensive population screening plays a very important role in the early diagnosis and prognosis of the breast cancer. X-ray and ultrasound are the most commonly used screening methods, and ultrasound is especially important for Asian women with dense breasts. However, ultrasound is greatly affected by the operator's skill and experience, and the diagnostic accuracy varies greatly. Artificial intelligence (AI) is a new method emerging in recent years, active in many medical fields and can effectively improve the diagnostic efficiency. However, previous researches on the application of AI in ultrasound are focused on single or multi-modality static ultrasound images. This multi-center study intends to evaluate the value of the detection and differential diagnosis of breast mass using deep learning AI-based real-time ultrasound examination.

Conditions

Interventions

TypeNameDescription
DEVICEYizhun BUSMSDuring the breast scanning, Yizhun BUSMS uses different color box to identify the breast lesion, and the box color indicates the risk grade of the lesion.

Timeline

Start date
2021-08-12
Primary completion
2022-08-31
Completion
2023-08-31
First posted
2022-07-05
Last updated
2022-07-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05443672. Inclusion in this directory is not an endorsement.